PROCEPT BioRobotics Corp — Director's Dealing 2024

Jan 11, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2024-01-09

Reporting Person: Nouri Alaleh (EVP, CLO, CORP. SEC.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-09	Common Stock	M	16000	$4.56	Acquired	63351	Direct
2024-01-09	Common Stock	S	16000	$44.9672	Disposed	47351	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-09	Stock Option (Right to Buy)	$4.56	M	16000	Disposed	2029-12-12	Common Stock (16000)	Direct

Footnotes

F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F2: Includes 418 shares acquired on May 12, 2023 under the Issuer's 2021 Employee Stock Purchase Plan.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.95 to $45.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F4: The Stock option was granted on December 12, 2019 and vested over a four year period.